Deutsche Bank Aktiengesellschaft Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $366.00

Intuitive Surgical (NASDAQ:ISRG) had its target price decreased by Deutsche Bank Aktiengesellschaft from $440.00 to $366.00 in a research report issued on Tuesday,MarketScreener reports. The brokerage presently has a “sell” rating on the medical equipment provider’s stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential downside of 8.96% from the company’s previous close.

Several other equities research analysts have also recently weighed in on the stock. HSBC reduced their target price on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reduced their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research note on Wednesday, April 22nd. Raymond James Financial reduced their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Evercore cut their price target on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research note on Monday, April 6th. Finally, TD Cowen cut their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $573.63.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $22.62 during mid-day trading on Tuesday, hitting $402.02. The company had a trading volume of 3,029,105 shares, compared to its average volume of 2,241,224. The business’s 50-day simple moving average is $452.19 and its 200-day simple moving average is $504.81. Intuitive Surgical has a 12 month low of $411.83 and a 12 month high of $603.88. The firm has a market cap of $142.38 billion, a P/E ratio of 49.89, a PEG ratio of 3.39 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. The firm’s revenue was up 23.0% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the sale, the director owned 239 shares of the company’s stock, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,833 shares of company stock worth $2,357,582 in the last three months. 0.60% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently modified their holdings of the company. Riversedge Advisors LLC increased its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after buying an additional 17 shares in the last quarter. Fiduciary Financial Group LLC increased its holdings in shares of Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares in the last quarter. Prosperity Consulting Group LLC increased its holdings in shares of Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares in the last quarter. Sunburst Financial Group LLC increased its holdings in shares of Intuitive Surgical by 4.3% during the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 20 shares in the last quarter. Finally, WoodTrust Financial Corp increased its holdings in shares of Intuitive Surgical by 0.5% during the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after buying an additional 20 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.